Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraVACCS: Quadrivalent HPV Vaccine for Prevention of Genital Warts Recurrence
NCT02750202Phase 3Completed
- Sponsor
- University of Pretoria
- Start
- Jul 2018
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of qHPV vaccine in genital warts, sponsored by University of Pretoria. Started Jul 2018; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
genital warts
Beyond the preview
Go deeper on NCT02750202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750202.